Evercore ISI analyst Amit Daryanani lowered the firm’s price target on IBM to $140 from $150 and keeps an In Line rating on the shares. IBM reported largely in-line March quarter revenue and maintained their calendar 2023 free cash flow guidance of $10.5B, but adjusted their revenue growth target to up 3-5% at constant currency, which is down moderately from a prior expectation for mid-single digit growth, the firm noted. Although IBM’s growth outlook was slightly reduced, Evercore views the updated guidance as prudent and "better than feared," the analyst tells investors.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IBM:
- IBM price target lowered to $140 from $150 at Stifel
- IBM price target lowered to $135 from $143 at Morgan Stanley
- Moderna, IBM to explore quantum computing, generative AI for mRNA science
- IBM says expects $2B in run rate savings by 2024 from cost saving initiatives
- Mixed Earnings Report Proves Good Enough for IBM